No CrossRef data available.
Article contents
The Experimental Psychology of Moral Enhancement: We Should If We Could, But We Can't
Published online by Cambridge University Press: 16 October 2018
Abstract
In this chapter we will review experimental evidence related to pharmacological moral enhancement. Firstly, we will present our recent study in which we found that a drug called propranolol could change moral judgements. Further research, which also investigated this, found similar results. Secondly, we will discuss the limitations of such approaches, when it comes to the idea of general “human enhancement”. Whilst promising effects on certain moral concepts might be beneficial to the development of theoretical moral psychology, enhancement of human moral behaviour in general – to our current understanding – has more side-effects than intended effects, making it potentially harmful. We give an overview of misconceptions when taking experimental findings beyond the laboratory and discuss the problems and solutions associated with the psychological assessment of moral behaviour. Indeed, how is morality “measured” in psychology, and are those measures reliable?
- Type
- Papers
- Information
- Royal Institute of Philosophy Supplements , Volume 83: Moral Enhancement: Critical Perspectives , October 2018 , pp. 313 - 328
- Copyright
- Copyright © The Royal Institute of Philosophy and the contributors 2018
References
1 Terbeck, S., Savulescu, J., Chesterman, L. P., and Cowen, P. J., ‘Noradrenaline Effects on Social Behaviour, Intergroup Relations, and Moral Decisions’, Neurosci Biobehav Rev. 66 (2016), 54–60CrossRefGoogle Scholar.
2 Greene, J. D., Sommerville, R. B., Nystrom, L. E., Darley, J. M., and Cohen, J. D., ‘An fMRI Investigation of Emotional Engagement in Moral Judgment’, Science 293:5537 (2001), 2105–2108CrossRefGoogle Scholar.
3 Foot, P., Virtues and Vices and Other Essays in Moral Philosophy (New York, USA: Oxford University Press, 1978)Google Scholar. See also Thomson, J. J., ‘Killing, Letting Die, and the Trolley Problem’, Monist 59:2 (1976), 204–217CrossRefGoogle ScholarPubMed.
4 For a description of the mechanism of chemical neurotransmission see Terbeck, et al., ‘Noradrenaline Effects on Social Behaviour, Intergroup Relations, and Moral Decisions’, 54–60.
5 Ax, A. F., ‘The Psychological Differentiation Between Fear and Anger in Humans’, Psychosom Med. 15:5 (1953), 433–442CrossRefGoogle Scholar.
6 Chamberlain, S. R., Mueller, U., Blackwell, A. D., Robbins, T. W., and Sahakian, B. J., ‘Noradrenergic Modulation of Working Memory and Emotional Memory in Humans’, Psychopharmacology 188:4 (2006), 397–407CrossRefGoogle ScholarPubMed.
7 Greene, et al., ‘An fMRI Investigation of Emotional Engagement in Moral Judgment’, 2105–2108.
8 Terbeck, S., Kahane, G., McTavish, S., Savulescu, J., Levy, N., Hewstone, M., and Cowen, P. J., ‘Beta Adrenergic Blockade Reduces Utilitarian Judgement’, Biological Psychology 92:2 (2013), 323–328Google ScholarPubMed.
9 For example see Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., and Johnson, B. T., ‘Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration’, PLoS Med. 5:2 (2008), 260–268CrossRefGoogle Scholar.
10 Crockett, M. J., Clark, L., Hauser, M. D., and Robbins, T. W., ‘Serotonin Selectively Influences Moral Judgment and Behavior Through Effects on Harm Aversion’, Proc Natl Acad Sci USA 107:40 (2010), 17433–17438CrossRefGoogle ScholarPubMed.
11 De Dreu, C. K. W., Greer, L. L., Van Kleef, G. A., Shalvi, S., and Handgraaf, M. J. J., ‘Oxytocin Promotes Human Ethnocentrism’, Proc Natl Acad Sci USA 108:4 (2011), 1262–1266CrossRefGoogle ScholarPubMed.
12 For a review see Levy, N., Douglas, T., Kahane, G., Terbeck, S., Cowen, P. J., Hewstone, M., and Savulescu, J., ‘Are You Morally Modified? The Moral Effects of Widely Used Pharmaceuticals’, Philos Psychiatr Psychol. 21:2 (2014), 111–125CrossRefGoogle ScholarPubMed.
13 For example see Zak, P. J., Stanton, A. A., and Ahmadi, S., ‘Oxytocin Increases Generosity in Humans’, PLoS One 2:11 (2007), 1–5CrossRefGoogle ScholarPubMed.
14 Terbeck, S., Kahane, G., McTavish, S., McCutcheon, R., Hewstone, M., Savulescu, J., and Norbury, R., ‘Beta-Adrenoceptor Blockade Modulates Fusiform Gyrus Activity to Black versus White Faces’, Psychopharmacology (Berl.) 232:16 (2015), 2951–2958CrossRefGoogle ScholarPubMed. See also Terbeck, S., Kahane, G., McTavish, S., Savulescu, J., Cowen, P. J., and Hewstone, M., ‘Propranolol Reduces Implicit Negative Racial Bias’, Psychopharmacology 222:3 (2012), 419–424CrossRefGoogle Scholar.
15 Terbeck, S., Akkus, F., Chesterman, L. P., and Hasler, G., ‘The Role of Metabotropic Glutamate Receptor 5 in the Pathogenesis of Mood Disorders and Addiction: Combining Preclinical Evidence with Human Positron Emission Tomography (PET) Studies’, Front Neurosci. 9:86 (2015), 1–10CrossRefGoogle Scholar.
16 De Jongh, R., Bolt, I., Schermer, M., and Olivier, B., ‘Botox for the Brain: Enhancement of Cognition, Mood and Pro-Social Behavior and Blunting of Unwanted Memories’, Neuroscience & Biobehavioral Reviews 32:4 (2008), 760–776CrossRefGoogle ScholarPubMed.
17 Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., and Johnson, B. T., ‘Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration’, PLoS Med. 5:2 (2008), 260–268CrossRefGoogle ScholarPubMed.
18 Silver, J. M., Yudofsky, S. C., Slater, J. A., Gold, R. K., Stryer, B. L., Williams, D. T., Wolland, H., and Endicott, J., ‘Propranolol Treatment of Chronically Hospitalized Aggressive Patients’, J. Neuropsychiatry Clin Neurosci. 11:3 (1999), 328–335CrossRefGoogle ScholarPubMed.
19 For example, see Douglas, T., ‘Moral Enhancement’, in Savulescu, J., ter Meulen, R., and Kahane, G. (eds), Enhancing Human Capacities (Oxford, UK: Wiley-Blackwell, 2011), 467–485Google Scholar.
20 Terbeck, S. and Chesterman, L. P., ‘Will There Ever Be a Drug With No or Negligible Side Effects? Evidence From Neuroscience’, Neuroethics 7:2 (2014), 189–194CrossRefGoogle Scholar.
21 Terbeck, et al., ‘Will There Ever Be a Drug With No or Negligible Side Effects? Evidence From Neuroscience’, 189–194.
22 Doris, J. M., ‘Introduction’, in Doris, J. M. (ed.), The Moral Psychology Handbook (New York, USA: Oxford University Press, 2010), 1–2CrossRefGoogle Scholar.
23 See Bartels, D. M., Bauman, C. W., Cushman, F. A., Pizarro, D. A., and McGraw, A. P., ‘Moral Judgment and Decision Making’, in Keren, G. and Wu, G. (eds), The Wiley Blackwell Handbook of Judgment and Decision Making (Chichester, UK: John Wiley & Sons, 2015), 478–515CrossRefGoogle Scholar. See also Cushman, F., Young, L., and Greene, J., ‘Our Multi-System Moral Psychology: Towards a Consensus View’, in Doris, J. M. (ed.), The Moral Psychology Handbook (New York, USA: Oxford University Press, 2010), 47–71CrossRefGoogle Scholar.
24 Thomson, Killing, Letting Die, and the Trolley Problem, 204–217.
See also Foot, Virtues and Vices.
25 Greene, et al., ‘An fMRI Investigation of Emotional Engagement in Moral Judgment’, 2105–2108.
26 Christensen, J. F., and Gomila, A., ‘Moral Dilemmas in Cognitive Neuroscience of Moral Decision-Making: A Principled Review’, Neurosci Biobehav Rev. 36:4 (2012), 1250CrossRefGoogle Scholar.
27 Hauser, M., Cushman, F., Young, L., Jin, R. Kang-Xing, and Mikhail, J., ‘A Dissociation Between Moral Judgments and Justifications’, Mind & Language 22:1 (2007), 1–21CrossRefGoogle Scholar.
28 Christensen and Gomila, ‘Moral Dilemmas in Cognitive Neuroscience of Moral Decision-Making: A Principled Review’, 1249–1264.
29 Bartels, et al., ‘Moral Judgment and Decision Making’, 154–161.
30 Tassy, S., Oullier, O., Mancini, J., and Wicker, B., ‘Discrepancies Between Judgment and Choice of Action in Moral Dilemmas’, Frontiers in Psychology 4:250 (2013), 1–8CrossRefGoogle Scholar.
31 Petrinovich, L. and O'Neill, P., ‘Influence of Wording and Framing Effects on Moral Intuitions’, Ethology and Sociobiology 17:3 (1996), 145–171CrossRefGoogle Scholar.
32 Kahane, G., Everett, J. A., Earp, B. D., Farias, M., and Savulescu, P., ‘Utilitarian Judgments in Sacrificial Moral Dilemmas Do Not Reflect Impartial Concern for the Greater Good’, Cognition 134 (2015), 193–209CrossRefGoogle Scholar.
33 For example, see Patil, I., ‘Trait Psychopathy and Utilitarian Moral Judgement: The Mediating Role of Action Aversion’, Journal of Cognitive Psychology 27:3 (2015), 349–366CrossRefGoogle Scholar. See also Cushman, F., Gray, K., Gaffey, A., and Mendes, W. B., ‘Simulating Murder: The Aversion to Harmful Action’, Emotion 12:1 (2012), 2–7CrossRefGoogle ScholarPubMed.
34 See Bartels, D. M. and Pizarro, D. A., ‘The Mismeasure of Morals: Antisocial Personality Traits Predict Utilitarian Responses to Moral Dilemmas’, Cognition 121:1 (2011), 154–161CrossRefGoogle Scholar. See also Djeriouat, H. and Tremoliere, B., ‘The Dark Triad of Personality and Utilitarian Moral Judgment: The Mediating Role of Honesty/Humility and Harm/Care’, Personality and Individual Differences 67 (2014), 11–16CrossRefGoogle Scholar. See also Gao, Y. and Tang, S., ‘Psychopathic Personality and Utilitarian Moral Judgment in College Students’, Journal of Criminal Justice 41:5 (2013), 342–349CrossRefGoogle Scholar.
35 Kahane, et al., ‘Utilitarian Judgments in Sacrificial Moral Dilemmas Do Not Reflect Impartial Concern for the Greater Good’, 12.
36 Christensen, J. F., Flexas, A., Calabrese, M., Gut, N. K., and Gomila, A., ‘Moral Judgment Reloaded: A Moral Dilemma Validation Study’, Frontiers in Psychology’ 5:607 (2014), 1–18CrossRefGoogle Scholar.
37 Christensen, et al., ‘Moral Judgment Reloaded’, 16.
38 Parsons, T. D., ‘Virtual Reality for Enhanced Ecological Validity and Experimental Control in the Clinical, Affective and Social Neurosciences’, Front Hum Neurosci. 9:660 (2015), 1–14CrossRefGoogle Scholar.
39 Navarrete, C. D., McDonald, M. M., Mott, M. L., and Asher, B., ‘Virtual Morality: Emotion and Action in a Simulated Three-Dimensional “Trolley Problem”’, Emotion 12:2 (2012), 364–370CrossRefGoogle Scholar.
40 Skulmowski, A., Bunge, A., Kaspar, K., and Pipa, G., ‘Forced-Choice Decision-Making in Modified Trolley Dilemma Situations: A Virtual Reality and Eye Tracking Study, Front Behav Neurosci. 8:426 (2014)CrossRefGoogle ScholarPubMed, 2.
41 FeldmanHall, O., Mobbs, D., Evans, D., Hiscox, L., Navrady, L., and Dalgleish, T., ‘What We Say and What We Do: The Relationship Between Real and Hypothetical Moral Choices’, Cognition 123:3 (2012), 434–441CrossRefGoogle Scholar.
42 For an overview of moral hypocrisy see Monin, B. and Merritt, A., ‘Moral Hypocrisy, Moral Inconsistency, and the Struggle for Moral Integrity’, in Mikulincer, M. and Shaver, P. R. (eds), The Social Psychology of Morality: Exploring the Causes of Good and Evil: Herzliya Series on Personality and Social Psychology (Washington, DC: American Psychological Association, 2012), 167–184Google Scholar.
43 Cima, M., Tonnaer, F., and Hauser, M. D., ‘Psychopaths Know Right From Wrong But Don't Care’, Soc Cogn Affect Neurosci. 5:1 (2010), 59–67CrossRefGoogle ScholarPubMed. See also Kiehl, K. A., ‘Without Morals: The Cognitive Neuroscience of Criminal Psychopaths’, in Sinnott-Armstrong, W. (ed.), Moral Psychology (Cambridge, USA: The MIT Press, 2008), 119–149Google Scholar. See also Tassy, S., Deruelle, C., Mancini, J., Leistedt, S., and Wicker, B., ‘High Levels of Psychopathic Traits Alters Moral Choice But Not Moral Judgment’, Front Hum Neurosci. 7 (2013)CrossRefGoogle Scholar: https://doi.org/10.3389/fnhum.2013.00229.
44 For an example see Francis, K. B., Howard, C., Howard, I. S., Gummerum, M., Ganis, G., Anderson, G., and Terbeck, S., ‘Virtual Morality: Transitioning from Moral Judgment to Moral Action?’, PLoS One 11:10 (2016), 1–22CrossRefGoogle Scholar.
45 Patil, I., Cogoni, C., Zangrando, N., Chittaro, L., and Silani, G., ‘Affective Basis of Judgment-Behavior Discrepancy in Virtual Experiences of Moral Dilemmas’, Soc Neurosci. 9:1 (2014), 95CrossRefGoogle ScholarPubMed.
46 See Navarrete, et al., ‘Virtual Morality: Emotion and Action in a Simulated Three-Dimensional “Trolley Problem”’, 364–370. See also Skulmowski, et al., ‘Forced-Choice Decision-Making in Modified Trolley Dilemma Situations: A Virtual Reality and Eye Tracking Study’, 1–16.
47 See Francis, et al., ‘Virtual Morality: Transitioning from Moral Judgment to Moral Action’, 1–22. See also Patil, et al., ‘Affective Basis of Judgment-Behavior Discrepancy in Virtual Experiences of Moral Dilemmas’, 94–107. See also X. Pan and M. Slater, ‘Confronting a Moral Dilemma in Virtual Reality: A Pilot Study’, Proceedings of the 25th BCS Conference on Human-Computer Interaction (2011).
48 For a full description see Francis, et al., ‘Virtual Morality: Transitioning from Moral Judgment to Moral Action’, 1–22.
49 Slater, M., Antley, A., Davison, A., Swapp, D., Guger, C., Barker, C., and Sanchez-Vives, M. V., ‘A Virtual Reprise of the Stanley Milgram Obedience Experiments’, PLoS One 1:1 (2006), 1–10CrossRefGoogle Scholar.
50 Rovira, A., Swapp, D., Spanlang, B., and Slater, M., ‘The Use of Virtual Reality in the Study of People's Responses to Violent Incidents’, Front Behav Neurosc. 3:59 (2009), 1–10Google Scholar.
51 M. Hauser, et al., ‘A Dissociation Between Moral Judgments and Justifications’, 4.
52 Francis, et al., ‘Virtual Morality: Transitioning from Moral Judgment to Moral Action’, 1–22.
53 Andreatta, P. B., Maslowski, E., Petty, S., Shim, W., Marsh, M., Hall, T., and Frankel, J., ‘Virtual Reality Triage Training Provides a Viable Solution for Disaster-Preparedness’, Academic Emergency Medicine 17:8 (2010), 870–876CrossRefGoogle Scholar.
54 Rovira, et al., ‘The Use of Virtual Reality in the Study of People's Responses to Violent Incidents’, 2, 9.
55 Carassa, A., Morganti, F., and Tirassa, M., ‘A Situated Cognition Perspective on Presence’, Proceedings of the Cognitive Science Society 27 (2005), 384Google Scholar.
56 See Parsons, ‘Virtual Reality for Enhanced Ecological Validity and Experimental Control in the Clinical, Affective and Social Neurosciences’, 1–14.
57 Slater, et al., ‘A Virtual Reprise of the Stanley Milgram Obedience Experiments’, 1–10.
58 Rovira, et al., ‘The Use of Virtual Reality in the Study of People's Responses to Violent Incidents’, 1–10.
59 Francis, et al., ‘Virtual Morality: Transitioning from Moral Judgment to Moral Action’, 1–22.
60 For an example see Greene, et al., ‘An fMRI Investigation of Emotional Engagement in Moral Judgment’, 2105–2108.
See also Cushman, F., ‘Action, Outcome, and Value: A Dual-System Framework for Morality’, Pers Soc Psychol Rev. 17:3 (2013), 273–292CrossRefGoogle ScholarPubMed.
See also Moll, J., de Oliveira-Souza, R., and Eslinger, P. J., ‘Morals and the Human Brain: A Working Model’, Neuroreport 14:3 (2003), 299–305CrossRefGoogle Scholar.
61 Bunge, A. and Skulmowski, A., ‘Descriptive and Pragmatic Levels of Empirical Ethics: Utilizing the Situated Character of Moral Concepts, Judgment, and Decision-Making’, in Luetge, C., Rusch, H., and Uhl, M. (eds), Experimental Ethics: Toward an Empirical Moral Philosophy (Basingstoke, UK: Palgrave Macmillan, 2014), 176Google Scholar.
62 Terbeck, et al., ‘Beta Adrenergic Blockade Reduces Utilitarian Judgement’, 323–328.
63 Terbeck, et al., ‘Beta-Adrenoceptor Blockade Modulates Fusiform Gyrus Activity to Black versus White Faces’, 2951–2958.
64 Terbeck and Chesterman, ‘Will There Ever Be a Drug With No or Negligible Side Effects? Evidence From Neuroscience’, 189–194.
65 Francis, et al., ‘Virtual Morality: Transitioning from Moral Judgment to Moral Action’, 1–22.